Guidelines of care for primary cutaneous melanoma

Journal of the American Academy of Dermatology

Volumn 45, Issue 4, 2001, Pages 579-586

  Sober, Arthur J ^b   Chuang, Tsu Yi ^b   Duvic, Madeleine ^b   Farmer, Evan R ^b   Grichnik, James M ^b   Halpern, Allan C ^b   Ho, Vincent ^b   Holloway, Victoria ^b   Hood, Antoinette F ^b   Johnson, Timothy M ^b   Lowery, Barbara J ^b  

^a AMERICAN ACADEMY OF DERMATOLOGY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MELANOMA; METASTASIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKIN BIOPSY;

EID: 17944370847     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.117044     Document Type: Article

References (44)

1. Effect of initial biopsy on prognosis in stage I invasive cutaneous malignant melanoma: Review of 1086 patients
2. Does biopsy influence survival in clinical stage I melanoma?
3. Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck
4. Rapid cytological diagnosis of primary skin tumours and tumour-like conditions
5. Prognostic models in melanoma
6. Predicting ten-year survival of patients with primary cutaneous melanoma: Corroboration of a prognostic model
7. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study
8. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
9. A prognostic model for predicting 10-year survival in patients with primary melanoma
10. Survival and prognostic factors in patients with localised cutaneous melanoma observed between 1980 and 1991 at the Istituto Dermopatico dell'Immacolata in Rome, Italy
11. Model predicting survival in stage I melanoma based on tumor progression
12. Prognostic factors in thin cutaneous malignant melanoma
13. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm)
14. Prognostic factors for cutaneous melanoma in Vaud, Switzerland
15. Predictors of late mortality in cutaneous malignant melanoma - A population-based study in Sweden
16. Breslow thickness and Clark level in melanoma: Support for including level in pathology reports and in American Joint Committee on Cancer Staging
17. Thick cutaneous melanoma: A reappraisal of prognostic factors
18. Thin cutaneous melanomas (≤1.5 mm): Identification of risk factors indicative of progression
19. Surgical margins for excision of primary cutaneous melanoma
20. Long-term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm
21. Ambulatory narrow excision for thin melanoma (≤2 mm): Results of a prospective study
22. Margin of resection in the management of primary melanoma
23. Local recurrence in malignant melanoma: Longterm results of the multi-institutional randomized surgical trial
24. Melanoma of the face: The safety of narrow excision margins
25. Melanoma recurrence after excision. Is a wide margin justified?
26. The effects of surgical treatment on survival and local recurrence of cutaneous malignant melanoma
27. Surgical margins and prognostic factors in patients with thick (>4 mm) primary melanoma
28. Diagnosis and treatment of early melanoma
29. Use of chest radiography in the initial evaluation of patients with localized melanoma
30. Evaluation of staging work-up in malignant melanoma
31. Stage I-II melanoma: The value of metastatic work-up
32. Predictive value of staging patients with clinical stage I malignant melanoma
33. Metastatic disease in patients with newly diagnosed malignant melanomas
34. Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma
35. Melanoma recurrence surveillance: Patient or physician based?
36. Follow-up in stage I cutaneous melanoma: An audit
37. A rational approach to melanoma follow-up in patients with primary cutaneous melanoma
38. Screening for cutaneous melanoma by skin self-examination
39. Follow-up recommendations for patients with American Joint Committee on Cancer stages I-III malignant melanoma
40. First recurrence analysis of 840 cutaneous melanomas: A proposal for a follow-up schedule
41. Frequency and duration of patient follow-up after treatment of a primary malignant melanoma
42. Cost-effectiveness of surveillance of stage I melanoma: A retrospective appraisal based on a 10-year experience in a dermatology department in France
43. Report of the Canadian Hypertension Society Consensus Conference: 1 Definitions, evaluation, and classification of hypertensive disorders in pregnancy
44. Report of the Canadian Hypertension Society Consensus Conference: 3 Pharmacologic treatment of hypertensive disorders in pregnancy